MNTR - Mentor Capital, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
1.37
-0.03 (-2.14%)
At close: 3:54PM EST
Stock chart is not supported by your current browser
Previous Close1.40
Open1.42
Bid0.00 x 0
Ask0.00 x 0
Day's Range1.35 - 1.44
52 Week Range0.45 - 4.82
Volume65,948
Avg. Volume274,616
Market Cap30.931M
Beta0.48
PE Ratio (TTM)N/A
EPS (TTM)-0.05
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire7 days ago

    Mentor Capital Backs Pueblo West in Colorado Cannabis

    SAN DIEGO, Feb. 12, 2018-- Mentor Capital, Inc. announced that it has extended into the Colorado cannabis market with its new investment in Pueblo West Organics, LLC. Cannabis veteran and Pueblo co-founder, ...

  • Business Wire8 days ago

    Mentor Capital Backs Pueblo West in Colorado Cannabis

    Mentor Capital, Inc. announced that it has extended into the Colorado cannabis market with its new investment in Pueblo West Organics, LLC. Cannabis veteran and Pueblo founder, Pat Leonard, comments, "Chet Billingsley and I first discussed working together back in 2013.

  • Business Wirelast month

    Mentor Capital Cash Investment in G Farma Now at $1.8 Million

    Mentor Capital, Inc. announced that during January it has funded an additional $900,000 into G FarmaLabs bringing the ten month multi-investment total by Mentor into G Farma to $1.8 million, which is in addition to an early and separate $600,000 stock transaction.

  • Business Wire2 months ago

    Mentor Capital Collecting $2 Million Year-End Cash from Bhang

    Mentor Capital, Inc. announced in a year-end note to shareholders that the corporation looks to immediately receive $2 million, successfully concluding its three-year litigation with Bhang Corporation.

  • Business Wire3 months ago

    Mentor Capital Reports 3rd Quarter 2017 10-Q

    Mentor Capital, Inc. announced that it has filed its quarterly 10-Q filing for the third quarter ended September 30, 2017 with the Securities and Exchange Commission.

  • Business Wire6 months ago

    Mentor Capital Reports Gains in Revenue, Book Value and Cash in 2nd Quarter 2017 10-Q

    Mentor Capital, Inc. announced that it has filed its quarterly Form 10-Q filing for the second quarter ended June 30, 2017 with the Securities and Exchange Commission.

  • Business Wire8 months ago

    Mentor Capital and G Farma Together at Oakland Cannabis Show

    The Mentor Capital, Inc. team will be answering investor questions on the going public process at the G FarmaLabs booth at the NCIA Cannabis Business Summit and Expo June 12 – 14 in Oakland, CA.

  • Business Wire9 months ago

    Mentor Capital Funds $2.4M in Five YTD Cannabis Investments

    Mentor Capital, Inc. announced that it has filed its quarterly 10-Q filing for the first quarter ended March 31, 2017 with the SEC.

  • Business Wire10 months ago

    Mentor Capital Again Invests in G FarmaLabs Success

    Mentor Capital, Inc. is happy to announce that it has extended its funding to G FarmaLabs by an extra 20% with an additional loan on top of last month’s million dollar investment in this global cannabis leader founded under the vision, energy and genius of Ata Gonzalez.

  • Business Wire10 months ago

    Mentor Capital Invests Second Tranche in Electrum Partners

    Mentor Capital, Inc. is pleased to announce it has again provided $100,000 in special project financing for cannabis advisory leader Electrum Partners, LLC. “Since our first $100,000 round of Electrum funding in March 2014, the Mentor team has gained great confidence in the business model developed by Leslie Bocskor, who now sits on the board of directors of GB Sciences and Grow Solutions Holdings ...

  • Business Wire10 months ago

    Mentor Capital Pays $300,000 Early to Long-Time Shareholders

    Mentor Capital, Inc. announces that early shareholders who together also hold approximately 3,000,000 Series B Warrants are having the 10 cent per warrant redemption payment for those warrants voluntarily paid out now by the Company approximately one-year in advance of the May 1, 2018 date previously scheduled with the Depository Trust & Clearing Corporation .

  • Business Wire10 months ago

    Mentor Capital Seeds Glaucoma – Cannabis Venture

    Mentor Capital, Inc. announces it has initiated funding for its GlauCanna venture for the use of medical marijuana in the treatment of glaucoma patients. Mentor will provide funding and business management for any commercial development and holds an 80% interest.

  • Business Wire10 months ago

    Mentor Capital Gains 4,000 Shareholders During First Quarter

    Mentor Capital, Inc. announced it has continued adding over 1,000 shareholders per month bringing its base of active shareholders who have Mentor shares in a brokerage account to 10,000 from 6,000 just at year end and 3,000 only three months earlier.

  • Business Wire11 months ago

    Mentor Capital Book Value up 66% to $5.6M Today, in 2016 10-K

    Mentor Capital, Inc. announced that it has filed its annual 10-K filing for the year ended December 31, 2016 with the SEC.

  • Business Wire11 months ago

    Mentor Capital Invests First $1.0 Million in G FarmaLabs

    Mentor Capital, Inc. announces it has closed and paid in cash and stock a $1.0 million multi-faceted financing program for G FarmaLabs Limited. The initial Mentor financing is structured to provide funding for real estate and working capital.

  • Business Wire11 months ago

    Mentor Capital Marks Recovery of $15 Million for Shareholders

    Mentor Capital, Inc. is now closing a long chapter in its history and estimates that has completely recovered $15 million for those 1,200 shareholders that Mentor uncovered had been defrauded by private syndicators before they became Mentor shareholders.

  • Business Wire11 months ago

    Mentor Capital CEO Contractually Limits His Stock Sales

    Mentor Capital, Inc. CEO Chet Billingsley reported that since August 15, 2016 he has contractually limited his stock sale orders to a level 13,500 to 16,000 shares in any given week and the Mentor share price rose 600%.

  • Business Wire11 months ago

    Mentor Capital Discusses Opioids vs. Cannabis at Congressman Rohrabacher Reception

    Mentor Capital, Inc. met with Congressman Dana Rohrabacher of Newport Beach at his reception by the Cannabis Host Committee in San Diego, March 6th, 2017. Mentor CEO Chet Billingsley, nicknamed “The Doc” by the Congressman, outlined in discussion how 20% of the opiate crises and 6,000 annual deaths could be avoided by the projected 20% substitution to legal cannabis from other illegal drugs that would ...

  • Business Wirelast year

    Mentor Capital Acquires $1.0 Million of GW Pharmaceuticals, Plc

    Mentor Capital, Inc. announced it has taken a $1.0 million position in the stock of GW Pharmaceuticals, Plc , a United Kingdom based group developing a portfolio of cannabinoid prescription medicines.